8-K Impact 6/10 Earnings

$AFL · AFLAC INC

November 4, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

Aflac reported Q3 2026 results: total revenues fell 31.0% to $3.27B, net earnings dropped 81.5% to $303M ($0.61 diluted EPS), and adjusted earnings declined 8.5% to $1.2B ($2.43 adjusted diluted EPS, down 2.4%). The decline was driven by $1.1B net investment losses from strategic portfolio repositioning, including $842M in sales/redemption losses and a $51M tax capital loss valuation allowance. The board declared a Q4 dividend of $0.61 per share, marking 44 consecutive years of increases.

  • Net earnings fell 81.5% to $303M, or $0.61 diluted EPS, from $1.6B a year ago.
  • Adjusted EPS declined 2.4% to $2.43, with adjusted earnings down 8.5% to $1.2B.
  • Net investment losses totaled $1.1B, including $842M in sales/redemption losses.
  • Aflac U.S. pretax adjusted earnings rose 31.5% to $493M; Japan pretax adjusted earnings fell 15.2% in yen.
  • Q4 dividend of $0.61 declared, marking 44 consecutive years of increases.
PeriodQ3 FY2026
ResultBeat
Revenue¥3.271B
Revenue YoY-31.0%
EPS¥2.43
EPS YoY-2.4%
Net income$303M

Extended-hours last trade $125.28, essentially flat (-0.02% vs regular close, +0.07% vs price-at-filing), suggesting investors largely shrugged off the headline net-earnings drop as non-cash repositioning noise.

Aflac's headline earnings collapse masks a deliberate portfolio repositioning, while adjusted results and the 44-year dividend streak show underlying stability.

The weak yen (158.49 vs 147.68 a year ago) continues to pressure Aflac Japan's dollar-reported results, a recurring headwind for U.S.-listed insurers with large Japanese operations.

The $1.1B net investment losses and $51M tax capital loss valuation allowance reflect realized repositioning costs; a $5.0B net unrealized loss on investment securities and derivatives also weighs on book value.

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →